Cytokine profile of bronchoalveolar secretion in prolonged course of community acquired pneumonia

Authors

DOI:

https://doi.org/10.26641/2307-0404.2022.1.254375

Keywords:

community-acquired pneumonia, complications, bronchoalveolar secretion, cytokines

Abstract

Despite existing studies on pathogenetic role of cytokine (CK) system in lung damage in pneumonia, there are still controversial issues of cytokine-mediated processes that lead to the prolongation of the inflammatory process in lung tissue in this pathology. The article presents the study of the cytokine profile of bronchoalveolar secretion (BAS) in the prolonged course of community-acquired pneumonia (CAP). To achieve the purpose of the research, in patients with prolonged CAP on the first and last 1-2 days of hospital stay the concentration of pro-inflammatory (IL-1β, IL-2, TNFα, IL-6, IL-8) and anti-inflammatory CK (IL-4 and IL-10) in BAS was determined. When studying the cytokine profile of BAS in the acute period of CAP, it was found that patients with a prolonged course of the disease subsequently had an increase in the concentration of pro-inflammatory CK (IL-1β, IL-6, IL-8, TNF-α and IL -2), reduction of anti-inflammatory (IL-4, IL-10) and more significant disproportion of the ratio of their opposition pools (IL-1β/IL-10 and TNF-α/IL-10) in BAS. In the conditions of the generally accepted therapy in patients with prolonged and not prolonged CAP course, various rate of improvement of indicators of CK in BAS is defined. In patients with prolonged CAP, the rate of progress of pro-inflammatory and anti-inflammatory CK was slower. At the time of discharge from the hospital, most patients had an imbalance of pro-inflammatory and anti-inflammatory CK with a predominance of pro-inflammatory activity in the bronchoalveolar space.

References

[Adapted evidence-based clinical guideline "community-acquired pneumonia in adults: etiology, pathogenesis, classification, diagnosis, antimicrobial therapy and prevention"]. Nat. Academy of Medical Sciences of Ukraine. Kyiv; 2019 Ukrainian. Available from http://www.ifp.kiev.ua/ftp1/metoddoc/Pneumonia_guidelines_2019_%5Brev29%5D.pdf

Antomonov MYu. [Mathematical treatment and analysis of medico-biological data. 2nd ed.]. Кyiv; 2018 p. 579. Russian.

Kashkin PK. [Immune system cytokines: basic properties and immunobiological activity]. Klin. lab. diagnostika. 1999;11:21-32. Russian.

Markelova E, Kostyushko A, Krasnikov V. [Pa¬thogenetic role of the in cytokine system changes at infectious and inflammatory diseases]. Pacific Medical Journal. 2008;(3):24-29. Russian.

Siljan WW, Holter JC, Nymo SH, Husebye E, Ueland T, Aukrust P, et al. Cyto¬kine responses, microbial aetiology and short‐term outcome in community‐acquired pneumonia. Eur J Clin Invest. 2018 Jan;48(1):e12865. doi: https://doi.org/10.1111/eci.12865

Yang M, Meng F, Gao M, Cheng G, Wang X. Cytokine signatures associate with disease severity in children with Mycoplasma pneumoniae pneumonia. Sci Rep.2019;9:17853.

doi: https://doi.org/10.1038/s41598-019-54313-9

Rosolowskia M, Oberleb V, Ahnerta P, Creutzc P, Witzenrathc M, Kiehntopfd M, et al. Dynamics of cytokines, immune cell counts and disease severity in patients with community-acquired pneumonia – Unravelling potential causal relationships. Cytokine. 2020 Dec;136:155263. doi: 10.1016/j.cyto.2020.155263

Quinton LJ, Walkey AJ, Mizgerd JP. Integrative Physiology of Pneumonia. Physiol Rev. 2018 Jul 1;(98):3:1417-64. doi: https://doi.org/10.1152/physrev.00032.2017

Robert PB. Technical aspects of bronchoalveolar lavage: recommendations for a standard procedure. Semin Respir Crit Care Med. 2007 Oct;28(5):475-85. doi: 10.1055/s-2007-991520

Savvateeva EN, Rubina AYu, Gryadunov DA. Biomarkers of Community-Acquired Pneumonia: A Key to Disease Diagnosis and Management. Biomed Res Int. 2019;2019:1701276. doi: https://doi.org/10.1155/2019/1701276

Aliberti S, Morlacchi LC, Faverio P, Fernandez-Botran R, Cosentini R, Mantero M, et al. Serum and exhaled breath condensate inflammatory cytokines in community-acquired pneumonia: a prospective cohort study. Pneumonia. 2016;8(8). doi: https://doi.org/10.1186/s41479-016-0009-7

Vijay K. Pulmonary Innate Immune Response Determines the Outcome of Inflammation During Pneu¬monia and Sepsis-Associated Acute Lung Injury Front Immunol. 2020;11:1722. doi: https://doi.org/10.3389/fimmu.2020.01722

Downloads

Published

2022-03-30

How to Cite

1.
Razumnyi R. Cytokine profile of bronchoalveolar secretion in prolonged course of community acquired pneumonia. Med. perspekt. [Internet]. 2022Mar.30 [cited 2024Apr.26];27(1):111-6. Available from: https://journals.uran.ua/index.php/2307-0404/article/view/254375

Issue

Section

CLINICAL MEDICINE